Literature DB >> 16316839

A case-control study of oxidized low density lipoproteins and preeclampsia risk.

Sixto E Sanchez1, Michelle A Williams, Martin Muy-Rivera, Chunfang Qiu, Surab Vadachkoria, Victor Bazul.   

Abstract

Diffuse vascular endothelial dysfunction, secondary to oxidative stress, is an important pathological feature of preeclampsia. Oxidative conversion of low density lipoproteins (LDL) to oxidized-LDL (Ox-LDL) is considered an important step in transforming macrophages into lipid-laden foam cells destined to develop into early atherosclerotic-like lesions. In our study of 95 women with preeclampsia and 100 controls, we evaluated the association between maternal plasma Ox-LDL concentrations and preeclampsia risk. Ox-LDL concentrations were measured using a solid phase two-site enzyme immunoassay. Plasma lipids were measured using standard enzymatic procedures. We used logistic regression to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounders. Plasma Ox-LDL concentrations were positively correlated with cholesterol, triglyceride (TG), and LDL concentrations in cases and controls, (Spearman's r ranging from 0.39-0.48, p-values all <0.01). There was no evidence of an increased risk of preeclampsia across increasing quartiles of Ox-LDL. The ORs for successive quartiles, with the lowest as the reference group, were as follows: 1.0, 1.1, 0.6, and 1.2. Women with extremely high concentrations of Ox-LDL (> or =73 U/L, the upper decile), as compared with those with lower values (<73 U/L) had a 2.7-fold increased risk of preeclampsia (95% CI 1.0-6.8). Women with high Ox-LDL and high TG concentrations (> or =284 mg/dl), as compared with those without these two factors, had a 9.6-fold increased preeclampsia risk (95% CI 2.0-45.6). Elevated Ox-LDL, particularly in conjunction with elevated TG, appears to be a risk factor of preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316839     DOI: 10.1080/09513590500154019

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  7 in total

1.  A case-control study of maternal blood mitochondrial DNA copy number and preeclampsia risk.

Authors:  Chunfang Qiu; Karin Hevner; Daniel A Enquobahrie; Michelle A Williams
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

2.  Increased oxidized low-density lipoprotein causes blood-brain barrier disruption in early-onset preeclampsia through LOX-1.

Authors:  Malou P H Schreurs; Carl A Hubel; Ira M Bernstein; Arun Jeyabalan; Marilyn J Cipolla
Journal:  FASEB J       Date:  2012-12-10       Impact factor: 5.191

Review 3.  Cholesterol in pregnancy: a review of knowns and unknowns.

Authors:  Änne Bartels; Keelin O'Donoghue
Journal:  Obstet Med       Date:  2011-07-28

4.  Comparison of lipid profile parameters and oxidized low-density lipoprotein between normal and preeclamptic pregnancies in a tertiary care hospital in Nepal.

Authors:  Santosh Timalsina; Prajwal Gyawali; Aseem Bhattarai
Journal:  Int J Womens Health       Date:  2016-10-26

5.  Levels of oxidized LDL, estrogens, and progesterone in placenta tissues and serum paraoxonase activity in preeclampsia.

Authors:  Serefden Açıkgöz; Ulkü Ozmen Bayar; Murat Can; Berrak Güven; Görkem Mungan; Suat Doğan; Vildan Sümbüloğlu
Journal:  Mediators Inflamm       Date:  2013-03-28       Impact factor: 4.711

6.  Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China.

Authors:  Wen-Yuan Jin; Sheng-Liang Lin; Ruo-Lin Hou; Xiao-Yang Chen; Ting Han; Yan Jin; Li Tang; Zhi-Wei Zhu; Zheng-Yan Zhao
Journal:  BMC Pregnancy Childbirth       Date:  2016-03-21       Impact factor: 3.007

Review 7.  Epilepsy management in pregnant HIV+ women in sub-Saharan Africa, clinical aspects to consider: a scoping review.

Authors:  Sonia Menon; Lenka Benova; Hillary Mabeya
Journal:  BMC Med       Date:  2020-11-17       Impact factor: 8.775

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.